2026 · New England Journal of Medicine

Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy

Palmer, Debra J.; Campbell, Dianne E.; Nanan, Ralph; Hsu, Peter S., and 9 others

Verdict

UNSCIENTIFIC

The study only partly follows the scientific method inside its paradigm, and the paradigm itself does not pass. The worse layer decides. The verdict is unscientific.

1·Study methodology · inside the paradigm

MIXED

Partly follows the scientific method within Allopathic Medicine.

2·Paradigm · Allopathic Medicine

UNSCIENTIFIC

Fails the tests. The worse layer decides.

How the verdict is decided

The verdict grades both layers: the paradigm this study assumes, and how the study was carried out inside it. Both must be scientific for the whole thing to be scientific. A clean method inside an unscientific paradigm is unscientific. An unscientific method inside a better paradigm is unscientific. A split on either layer is mixed. The worse layer decides.

1·Study methodology

Did this study test its claim with methods that are independent, falsifiable, and non-circular?

MIXED

This study claims that a maternal diet high in eggs and peanuts during pregnancy and lactation did not reduce the risk of IgE-mediated egg or peanut allergy in infants at one year of age. The tests split.

Independently Verifiable

Fail

The allergy count is a lab signal the allergy model reads as IgE disease, not something a stranger could see in the infant.

Falsifiable

Pass

The randomization was real and the null result was reported, so the diet claim could die and did.

Non-Circular

Fail

The test that defines the outcome was built from the allergy model the conclusion is written in.

Why

They randomized more than 2,000 pregnant women to eat either a lot of egg and peanut or a little, from mid-pregnancy through four months of breastfeeding. The diets are real and the assignment was honest. But the outcome they counted was not a child breaking out in hives after eating egg. It was a lab signal that the allergy model interprets as an IgE antibody, used to sort each infant into allergic or not allergic. Strip the model away and you have blood draws, numbers on screens, and 83 tags versus 89 tags. The null was reported plainly, so the diet claim could die in this design and it did. What was counted is still the model's category, not a visible sick child.

2·Paradigm · Allopathic Medicine

Does the framework this study assumes pass the three tests?

UNSCIENTIFIC

Independently Verifiable

Fail

Nobody has seen an IgE antibody make a child sick; the model reads it out of an assay signal.

Falsifiable

Fail

A positive test without symptoms becomes sensitization, symptoms without a positive test become non-IgE mediated, so no outcome counts against the model.

Non-Circular

Fail

The IgE assay was built to find what the immune model already named, and the assay's output is the model's only evidence.

Why

The allergen-immunology branch of allopathy names a protein it calls IgE as the cause of food allergy. Nobody has watched that antibody make a child sick. The assay produces a signal and the model tells the clinician the signal means sensitized. This trial shows the protection at work. A child who tests positive and eats peanut without reacting is called sensitized but tolerant. A child who reacts with a negative test is called non-IgE mediated. The model treats the tagged signal as the disease and never asks what condition of the infant's body made it respond to an ordinary food protein at all. No result can kill a framework that renames every outcome it gets.

From the study

Methods
The primary outcome was IgE-mediated egg or peanut allergy in the infant at 1 year of age.
Results
There was no significant difference in the percentage of infants with IgE-mediated egg or peanut allergy between the maternal high egg-peanut group (83 of 1066, 7.8%) and the standard-diet group (89 of 1064, 8.4%) (relative risk, 0.93; 95% confidence interval, 0.69 to 1.26; P = 0.65).
Methods
pregnant women whose unborn child had at least two biologic family members with medically diagnosed allergic disease were eligible to participate